SB 997: Pupil health: opioid antagonists and fentanyl test strips.
- Session Year: 2023-2024
- House: Senate
- Latest Version Date: 2024-09-28
Current Status:
Passed
(2024-09-28: Chaptered by Secretary of State. Chapter 872, Statutes of 2024.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would prohibit school districts, county offices of education, and charter schools from prohibiting pupils in middle schools, junior high schools, high schools, or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would prohibit school districts, county offices of education, and charter schools from prohibiting pupils in middle schools, junior high schools, high schools, or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would authorize prohibit school districts, county offices of education, and charter schools to develop and adopt a policy that allows from prohibiting pupils in middle schools, junior high schools, high schools, and adult schools to carry or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose. The bill would, for those local educational agencies that choose to develop and adopt a policy, to include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved opioid antagonist. The bill would require public middle schools, junior high schools, high schools, and adult schools that are operated by a local educational agency to (1) stock and distribute fentanyl test strips, as provided, (2) notify pupils about the presence and location of fentanyl test strips, as provided, and (3) allow pupils to carry fentanyl test strips, as provided. To the extent the bill would impose additional duties on local educational agencies, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would authorize school districts, county offices of education, and charter schools to develop and adopt a policy that allows pupils in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal product or any other federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose. The bill would, for those local educational agencies that choose to develop and adopt a policy, to include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal product or other federally approved opioid antagonist. The bill would require public middle schools, junior high schools, high schools, and adult schools that are operated by a local educational agency to (1) stock and distribute fentanyl test strips, as provided, (2) notify pupils about the presence and location of fentanyl test strips, as provided, and (3) allow pupils to carry fentanyl test strips, as provided. To the extent the bill would impose additional duties on local educational agencies, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would authorize school districts, county offices of education, and charter schools to develop and adopt a policy that allows pupils in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal spray product or any other federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose. The bill would, for those local educational agencies that choose to develop and adopt a policy, to include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal spray product or other federally approved opioid antagonist. The bill would require public middle schools, junior high schools, high schools, and adult schools that are operated by a local educational agency to (1) stock and distribute fentanyl test strips, as provided, and to (2) notify pupils about the presence and location of fentanyl test strips. strips, and (3) allow pupils to carry fentanyl test strips, as provided. To the extent the bill would impose additional duties on local educational agencies, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would authorize school districts, county offices of education, and charter schools to develop and adopt a policy that allows pupils in middle schools and high schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal spray, spray or any other federally approved opioid antagonist, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose. The bill would, for those local educational agencies that choose to develop and adopt a policy, to include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal spray or other federally approved opioid antagonist. The bill would require public middle schools and high schools, junior high schools, high schools, and adult schools that are operated by a local educational agency to stock and distribute fentanyl test strips, as provided, and to notify pupils about the presence and location of fentanyl test strips. To the extent the bill would impose additional duties on local educational agencies, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of any school district to give diligent care to the health and physical development of pupils. Existing law authorizes a school district, county office of education, and charter school to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose, as provided.
This bill would authorize school districts, county offices of education, and charter schools to develop and adopt a policy that allows pupils in middle schools and high schools to carry a federally approved naloxone hydrochloride nasal spray, as provided, for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose. The bill would require public middle schools and high schools that are operated by a local educational agency to stock and distribute fentanyl test strips, as provided, and to notify pupils about the presence and location of fentanyl test strips. To the extent the bill would impose additional duties on local educational agencies, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(a)Notwithstanding any other law or regulation, local educational agencies shall not prohibit pupils in middle schools, junior high schools, high schools, or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
(a)Notwithstanding any other law or regulation, local educational agencies shall not prohibit pupils in middle schools, junior high schools, high schools, or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
(a)Local Notwithstanding any other law or regulation, local educational agencies may develop and adopt a policy that allows shall not prohibit pupils in middle schools, junior high schools, high schools, and adult schools to carry or adult schools, while on a schoolsite or participating in school activities, from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(b)Local educational agencies that develop and adopt a policy pursuant to subdivision (a) shall include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved opioid antagonist.(c)(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
SEC. 2.Section 49414.9 is added to the Education Code, to read:49414.9.(a)Middle schools, junior high schools, high schools, and adult schools operated by a local educational agency shall do all of the following:(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips to pupils as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.(2)Notify pupils of the presence and location of fentanyl test strips at least once per school year using existing means of communication.(3)Allow pupils to carry fentanyl test strips on the pupils person or in the pupils personal property.(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.(a)Local educational agencies may develop and adopt a policy that allows pupils in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal product or any other federally approved opioid antagonist for over-the-counter, nonprescription over-the-counter use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(b)Local educational agencies that develop and adopt a policy pursuant to subdivision (a) shall include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal product or other federally approved opioid antagonist.
(c)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
SEC. 2.Section 49414.9 is added to the Education Code, to read:49414.9.(a)Middle schools, junior high schools, high schools, and adult schools operated by a local educational agency shall do all of the following:
(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips to pupils as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(2)Notify pupils of the presence and location of fentanyl test strips. strips at least once per school year using existing means of communication.
(3)Allow pupils to carry fentanyl test strips on the pupils person or in the pupils personal property.
(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)(1)Local educational agencies may develop and adopt a policy that allows pupils in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal spray product or any other federally approved opioid antagonist for over-the-counter, nonprescription use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(2)(b)Local educational agencies that develop and adopt a policy pursuant to subdivision (a) shall include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal spray product or other federally approved opioid antagonist.
(b)Middle schools, junior high schools, high schools, and adult schools operated by a local educational agency shall do both of the following:(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.(2)Notify pupils of the presence and location of fentanyl test strips.(c)For purposes of this section, a local educational agency means a school district, county office of education, or charter schools. school.
SEC. 2.Section 49414.9 is added to the Education Code, to read:49414.9.(a)Middle schools, junior high schools, high schools, and adult schools operated by a local educational agency shall do all of the following:
(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(2)Notify pupils of the presence and location of fentanyl test strips.
(3)Allow pupils to carry fentanyl test strips on the pupils person or in the pupils personal property.
(b)For purposes of this section, local educational agency means a school district, county office of education, or charter school.
SEC. 2.SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)(1)Local educational agencies may develop and adopt a policy that allows pupils in middle schools and high schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal spray or any other federally approved opioid antagonist for over-the-counter, nonprescription use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(2)Local educational agencies that develop and adopt a policy pursuant to subdivision (a) shall include, at a minimum, a requirement that a pupil has received instruction in the administration of the federally approved naloxone hydrochloride nasal spray or other federally approved opioid antagonist.
(b)Middle schools and high schools, junior high schools, high schools, and adult schools operated by a local educational agency shall do both of the following:
(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(2)Notify pupils of the presence and location of fentanyl test strips.
(c)For purposes of this section, a local educational agency means a school district, county office of education, or charter schools.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)Local educational agencies may develop and adopt a policy that allows pupils in middle schools and high schools to carry a federally approved naloxone hydrochloride nasal spray for over-the-counter, nonprescription use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
(b)Middle schools and high schools operated by a local educational agency shall do both of the following:
(1)Stock fentanyl test strips in a secured location and distribute the fentanyl test strips as needed. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(2)Notify pupils of the presence and location of fentanyl test strips.
(c)For purposes of this section, a local educational agency means a school district, county office of education, or charter schools.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
|
Date
|
Status
|
|---|---|
| Sep 28, 2024 | Chaptered by Secretary of State. Chapter 872, Statutes of 2024. |
| Sep 28, 2024 | Approved by the Governor. |
| Sep 10, 2024 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 30, 2024 | Assembly amendments concurred in. (Ayes 40. Noes 0. Page 5748.) Ordered to engrossing and enrolling. |
| Aug 29, 2024 | Ordered to special consent calendar. |
| Aug 28, 2024 | In Senate. Concurrence in Assembly amendments pending. |
| Aug 28, 2024 | Read third time. Passed. (Ayes 77. Noes 0. Page 6697.) Ordered to the Senate. |
| Aug 22, 2024 | Ordered to third reading. |
| Aug 22, 2024 | Read third time and amended. |
| Aug 19, 2024 | Read second time. Ordered to third reading. |
| Aug 15, 2024 | From committee: Do pass. (Ayes 14. Noes 0.) (August 15). |
| Jul 2, 2024 | July 2 set for first hearing. Placed on suspense file. |
| Jun 17, 2024 | Read second time and amended. Re-referred to Com. on APPR. |
| Jun 13, 2024 | From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (June 12). |
| Jun 3, 2024 | Referred to Com. on ED. |
| May 24, 2024 | In Assembly. Read first time. Held at Desk. |
| May 23, 2024 | Read third time. Passed. (Ayes 37. Noes 0. Page 4178.) Ordered to the Assembly. |
| May 20, 2024 | Ordered to special consent calendar. |
| May 16, 2024 | Read second time. Ordered to third reading. |
| May 16, 2024 | From committee: Do pass. (Ayes 7. Noes 0. Page 3967.) (May 16). |
| May 10, 2024 | Set for hearing May 16. |
| May 6, 2024 | May 6 hearing: Placed on APPR suspense file. |
| Apr 26, 2024 | Set for hearing May 6. |
| Apr 23, 2024 | From committee: Do pass and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 3702.) (April 22). Re-referred to Com. on APPR. |
| Apr 18, 2024 | Set for hearing April 22. |
| Apr 18, 2024 | April 24 hearing postponed by committee. |
| Apr 8, 2024 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. |
| Apr 3, 2024 | Set for hearing April 24. |
| Mar 21, 2024 | Read second time and amended. Re-referred to Com. on HEALTH. |
| Mar 20, 2024 | From committee: Do pass as amended and re-refer to Com. on HEALTH with recommendation: To consent calendar. (Ayes 7. Noes 0. Page 3378.) (March 20). |
| Mar 1, 2024 | Set for hearing March 20. |
| Feb 14, 2024 | Referred to Coms. on ED. and HEALTH. |
| Feb 1, 2024 | From printer. May be acted upon on or after March 2. |
| Jan 31, 2024 | Introduced. Read first time. To Com. on RLS. for assignment. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 30, 2024 | Special Consent SB997 Portantino et al. | Senate Floor |
Passed |
|
| Aug 28, 2024 | SB 997 Portantino Senate Third Reading By Boerner | Assembly Floor |
Passed |
|
| Aug 15, 2024 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Jun 12, 2024 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Education |
Passed |
|
| May 23, 2024 | Special Consent SB997 Portantino et al. | Senate Floor |
Passed |
|
| May 16, 2024 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| May 6, 2024 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 22, 2024 | Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar | Senate Standing Committee on Health |
Passed |
|
| Mar 20, 2024 | Do pass as amended, but first amend, and re-refer to the Committee on [Health] with the recommendation: To Consent Calendar | Senate Standing Committee on Education |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| Alameda County Office Of Education | ** Support | |
| American Academy Of Pediatrics, California | ** Support | |
| Caadpe | ** Support | |
| California Association of Alcohol and Drug Program Executives | ** Support | |
| California State PTA | ** Support | |
| California Youth Empowerment Network | ** Support | |
| City and County of San Francisco | ** Support | |
| Generation Up | ** Support | |
| Mental Health America of California | ** Support | |
| National Association of Pediatric Nurse Practitioners | ** Support | |
| San Francisco Youth Commission | ** Support | |
| Steinberg Institute | ** Support | |
| the los angeles trust for children's health | ** Support |
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 997 |
UNFINISHED BUSINESS
Bill No: SB 997
Author: Portantino (D), et al.
Amended: 8/22/24
Vote: 21
SENATE EDUCATION COMMITTEE: 7-0, 3/20/24
AYES: Newman, Ochoa Bogh, Cortese, Glazer, Gonzalez, Smallwood-Cuevas, Wilk
SENATE HEALTH COMMITTEE: 11-0, 4/22/24
AYES: Roth, Nguyen, Glazer, Gonzalez, Grove, Hurtado, Limón, Menjivar, Rubio, Smallwood-Cuevas, Wiener
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/16/24
AYES: Caballero, Jones, Ashby, Becker, Bradford, Seyarto, Wahab
SENATE FLOOR: 37-0, 5/23/24
AYES: Alvarado-Gil, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
NO VOTE RECORDED: Allen, Archuleta, Newman
ASSEMBLY FLOOR: 77-0, 8/28/24 - See last page for vote
SUBJECT: Pupil health: opioid antagonists and fentanyl test strips
SOURCE: Author
DIGEST:
This bill prohibits local educational agencies (LEAs) from prohibiting students in middle schools, junior high schools, high schools, or adult schools, from carrying fentanyl test strips, or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose while on a schoolsite, or while participating in school activities.
Assembly Amendments
narrow the bill to prohibit an LEA from prohibiting students in middle schools, junior high schools, high schools, or adult schools, from carrying fentanyl test strips, or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose while on a schoolsite, or while participating in school activities.
ANALYSIS:
Existing Law:
Education Code (EC)
- Requires the governing board of each community college district (CCD) and the Trustees of the California State University (CSU), and requests the Regents of the University of California (UC), to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center. (EC § 67384)
- Requires COEs, among other requirements, to be eligible for funds to purchase at least two units for each middle school, junior high school, high school, and adult school schoolsite within their jurisdiction, but are not required to participate. (EC § 49414.8)
- Requires an LEA that serve pupils in any of grades 7 to 12, to include in their school safety plan, a protocol in the event a pupil is suffering or is reasonably believed to be suffering from an opioid overdose. (EC § 32282(K))
- Permits a school nurse or trained personnel who has volunteered to provide emergency naloxone or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose. (EC § 49414.3(a))
- Requires an LEA, COE, or charter school electing to utilize naloxone or another opioid antagonist for emergency aid to ensure that each employee who volunteers are provided defense and indemnification by the LEA, COE, or charter school for any and all civil liability. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file. (EC § 49414.3(i))
- Provides a school no more than two weeks to restock their supply of naloxone or another opioid antagonist after use. (EC § 49414.3(h)
This bill:
- Prohibit LEAs from prohibiting students in middle schools, junior high schools, high schools, or adult schools from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose, while on a schoolsite or while participating in school activities.
- Defines LEA as a school district, county office of education (COE), or charter school.
Comments
- Need for the bill. According to the author, “It is nearly impossible to tell if drugs have been laced with fentanyl unless you test your drugs with testing strips. Drug testing strips still hold a negative association with drug use, thereby stigmatizing this lifesaving tool. If we want to help our young people, we must take steps that preserve their livelihood. Test strips are inexpensive and typically give results within 5 minutes, which can be the difference between life or death. Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry with live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose faster.”
- Addressing Fentanyl Among California Youth. Pursuant to AB 1748 (Mayes, Chapter 557, Statutes of 2016), among other things, requires the Superintendent of Public Instruction is required to establish minimum training standards for school employees who volunteer to administer naloxone or another opioid antagonist. In addition to setting minimum training standards, the CDE must maintain on its website a clearinghouse for best practices in training nonmedical personnel to administer naloxone or another opioid antagonist to pupils.
The CDE, in conjunction with the California Department of Public Health (CDPH), provides LEAs with resources and information that they can readily share with parents and students to help keep them safe. The shareable Fentanyl Awareness and Prevention toolkit page offers information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
While schools are authorized but not required to stock naloxone, some LEAs and COEs have also adjusted to address this growing crisis. For example, the Lake County Office of Education and Washington Unified School District in West Sacramento recently implemented a local school naloxone policy consistent with state statutes (which requires school employees who elect to administer naloxone, to be trained in the administration, and to keep the naloxone stocked and stored appropriately). San Diego Unified School District created its naloxone toolkit to aid other LEAs and inform parents and guardians.
Further, the legislature has adopted a series of legislation such as SB 10 (Cortese, Chapter 856, Statutes of 2023), which requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023) that, among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists, with the intent that it complement efforts of the Naloxone Distribution Project; and AB 889 (Joe Patterson, Chapter 123, Statutes of 2023) which required LEA, COE, and charter school to annually inform parents or guardians of the dangers associated with using synthetic drugs and post this information on their respective internet websites.
- Statewide Standing Order for Naloxone. Naloxone can help reduce opioid overdose deaths in California, but many organizations find it challenging to obtain the required standing order to get naloxone from healthcare providers. CDPH issued the standing order in 2017 to address this need and support equitable naloxone access. The standing order:
- Allows community organizations and other non-prescribing entities (organizations that do not employ or contract with a medical provider that has a license to prescribe and can issue a standing order and provide oversight for the distribution and administration of naloxone) in California that are not currently working with a physician to distribute naloxone to a person at risk of an opioid-related overdose or to a family member, friend, or another person in a position to assist; and
- Allows for the administration of naloxone by a family member, friend, or other person to a person experiencing or reasonably suspected of experiencing an opioid overdose.
Among the organizations and entities that can distribute naloxone under the order are colleges and universities. An individual at risk of experiencing an overdose or someone who can assist an individual at risk is allowed to do so. Under the statewide standing order, staff of community organizations and other entities distributing naloxone must be trained. They are also required to provide training to individuals who receive naloxone from them. Colleges, schools, and other organizations may apply to use the statewide standing order if they meet certain conditions.
- The U.S. Food and Drug Administration: Approval of Over-The-Counter Naloxone. On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.
The FDA first approved naloxone nasal spray in 2015 as a prescription drug. In accordance with a process to change the status of a drug from prescription to nonprescription, the manufacturer provided data demonstrating that the drug is safe and effective for use as directed in its proposed labeling. The manufacturer also showed that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional. The application to approve naloxone nasal spray for OTC use was granted priority review status and was the subject of an advisory committee meeting in February 2023, where committee members voted unanimously to recommend it be approved for marketing without a prescription.
On July 28, 2023, the FDA approved RiVive, a (3mg) naloxone nasal spray for OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription.
- Fentanyl test strips. According to CDPH’s website, fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California’s syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 8/28/24)
Alameda County Office of Education
American Academy of Pediatrics, California
CAADPE
California Association of Alcohol and Drug Program Executives
California State PTA
California Youth Empowerment Network
City and County of San Francisco
Generation Up
Mental Health America of California
National Association of Pediatric Nurse Practitioners
San Francisco Youth Commission
Steinberg Institute
The Los Angeles Trust for Children's Health
1 Individual
OPPOSITION: (Verified 8/28/24)
None received
ARGUMENTS IN SUPPORT: Click or tap here to enter text.
According to Generation Up, “Fentanyl, an opioid that proves to be up to 50 times more intense than Heroin, is one of the overarching drugs driving the rate of drug-related overdoses in California and the United States. When laced, fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, Naloxone, which is available to purchase over-the-counter, can help counteract its effects. There has been an alarming change in the opioid epidemic, which remains a critical public health issue in California. Synthetic opioids, including fentanyl, have significantly contributed to the surge in drug-related overdose deaths. As reported by the California Department of Public Health, the state of California carries a total of 7,000 opioid-related deaths, with Fentanyl being the culprit of 88% of the deaths. SB 997 calls for the implementation of measures to deter the rising rate of opioid-related deaths among middle school and high school students. If students are engaging in drugs, the focus is to ensure safe use that avoids potential death from substance use."
Click here to enter text.
Prepared by: Kordell Hampton / ED. / (916) 651-4105
8/29/24 11:06:22
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 997 |
UNFINISHED BUSINESS
Bill No: SB 997
Author: Portantino (D), et al.
Amended: 8/22/24
Vote: 21
SENATE EDUCATION COMMITTEE: 7-0, 3/20/24
AYES: Newman, Ochoa Bogh, Cortese, Glazer, Gonzalez, Smallwood-Cuevas, Wilk
SENATE HEALTH COMMITTEE: 11-0, 4/22/24
AYES: Roth, Nguyen, Glazer, Gonzalez, Grove, Hurtado, Limón, Menjivar, Rubio, Smallwood-Cuevas, Wiener
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/16/24
AYES: Caballero, Jones, Ashby, Becker, Bradford, Seyarto, Wahab
SENATE FLOOR: 37-0, 5/23/24
AYES: Alvarado-Gil, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
NO VOTE RECORDED: Allen, Archuleta, Newman
ASSEMBLY FLOOR: 59-0, 8/28/24 – Roll call vote not available
SUBJECT: Pupil health: opioid antagonists and fentanyl test strips
SOURCE: Author
DIGEST:
This bill prohibits local educational agencies (LEAs) from prohibiting students in middle schools, junior high schools, high schools, or adult schools, from carrying fentanyl test strips, or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose while on a schoolsite, or while participating in school activities.
Assembly Amendments
narrow the bill to prohibit an LEA from prohibiting students in middle schools, junior high schools, high schools, or adult schools, from carrying fentanyl test strips, or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose while on a schoolsite, or while participating in school activities.
ANALYSIS:
Existing Law:
Education Code (EC)
- Requires the governing board of each community college district (CCD) and the Trustees of the California State University (CSU), and requests the Regents of the University of California (UC), to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center. (EC § 67384)
- Requires COEs, among other requirements, to be eligible for funds to purchase at least two units for each middle school, junior high school, high school, and adult school schoolsite within their jurisdiction, but are not required to participate. (EC § 49414.8)
- Requires an LEA that serve pupils in any of grades 7 to 12, to include in their school safety plan, a protocol in the event a pupil is suffering or is reasonably believed to be suffering from an opioid overdose. (EC § 32282(K))
- Permits a school nurse or trained personnel who has volunteered to provide emergency naloxone or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose. (EC § 49414.3(a))
- Requires an LEA, COE, or charter school electing to utilize naloxone or another opioid antagonist for emergency aid to ensure that each employee who volunteers are provided defense and indemnification by the LEA, COE, or charter school for any and all civil liability. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file. (EC § 49414.3(i))
- Provides a school no more than two weeks to restock their supply of naloxone or another opioid antagonist after use. (EC § 49414.3(h)
This bill:
- Prohibit LEAs from prohibiting students in middle schools, junior high schools, high schools, or adult schools from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose, while on a schoolsite or while participating in school activities.
- Defines LEA as a school district, county office of education (COE), or charter school.
Comments
- Need for the bill. According to the author, “It is nearly impossible to tell if drugs have been laced with fentanyl unless you test your drugs with testing strips. Drug testing strips still hold a negative association with drug use, thereby stigmatizing this lifesaving tool. If we want to help our young people, we must take steps that preserve their livelihood. Test strips are inexpensive and typically give results within 5 minutes, which can be the difference between life or death. Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry with live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose faster.”
- Addressing Fentanyl Among California Youth. Pursuant to AB 1748 (Mayes, Chapter 557, Statutes of 2016), among other things, requires the Superintendent of Public Instruction is required to establish minimum training standards for school employees who volunteer to administer naloxone or another opioid antagonist. In addition to setting minimum training standards, the CDE must maintain on its website a clearinghouse for best practices in training nonmedical personnel to administer naloxone or another opioid antagonist to pupils.
The CDE, in conjunction with the California Department of Public Health (CDPH), provides LEAs with resources and information that they can readily share with parents and students to help keep them safe. The shareable Fentanyl Awareness and Prevention toolkit page offers information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
While schools are authorized but not required to stock naloxone, some LEAs and COEs have also adjusted to address this growing crisis. For example, the Lake County Office of Education and Washington Unified School District in West Sacramento recently implemented a local school naloxone policy consistent with state statutes (which requires school employees who elect to administer naloxone, to be trained in the administration, and to keep the naloxone stocked and stored appropriately). San Diego Unified School District created its naloxone toolkit to aid other LEAs and inform parents and guardians.
Further, the legislature has adopted a series of legislation such as SB 10 (Cortese, Chapter 856, Statutes of 2023), which requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023) that, among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists, with the intent that it complement efforts of the Naloxone Distribution Project; and AB 889 (Joe Patterson, Chapter 123, Statutes of 2023) which required LEA, COE, and charter school to annually inform parents or guardians of the dangers associated with using synthetic drugs and post this information on their respective internet websites.
- Statewide Standing Order for Naloxone. Naloxone can help reduce opioid overdose deaths in California, but many organizations find it challenging to obtain the required standing order to get naloxone from healthcare providers. CDPH issued the standing order in 2017 to address this need and support equitable naloxone access. The standing order:
- Allows community organizations and other non-prescribing entities (organizations that do not employ or contract with a medical provider that has a license to prescribe and can issue a standing order and provide oversight for the distribution and administration of naloxone) in California that are not currently working with a physician to distribute naloxone to a person at risk of an opioid-related overdose or to a family member, friend, or another person in a position to assist; and
- Allows for the administration of naloxone by a family member, friend, or other person to a person experiencing or reasonably suspected of experiencing an opioid overdose.
Among the organizations and entities that can distribute naloxone under the order are colleges and universities. An individual at risk of experiencing an overdose or someone who can assist an individual at risk is allowed to do so. Under the statewide standing order, staff of community organizations and other entities distributing naloxone must be trained. They are also required to provide training to individuals who receive naloxone from them. Colleges, schools, and other organizations may apply to use the statewide standing order if they meet certain conditions.
- The U.S. Food and Drug Administration: Approval of Over-The-Counter Naloxone. On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.
The FDA first approved naloxone nasal spray in 2015 as a prescription drug. In accordance with a process to change the status of a drug from prescription to nonprescription, the manufacturer provided data demonstrating that the drug is safe and effective for use as directed in its proposed labeling. The manufacturer also showed that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional. The application to approve naloxone nasal spray for OTC use was granted priority review status and was the subject of an advisory committee meeting in February 2023, where committee members voted unanimously to recommend it be approved for marketing without a prescription.
On July 28, 2023, the FDA approved RiVive, a (3mg) naloxone nasal spray for OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription.
- Fentanyl test strips. According to CDPH’s website, fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California’s syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 8/28/24)
Alameda County Office of Education
American Academy of Pediatrics, California
CAADPE
California Association of Alcohol and Drug Program Executives
California State PTA
California Youth Empowerment Network
City and County of San Francisco
Generation Up
Mental Health America of California
National Association of Pediatric Nurse Practitioners
San Francisco Youth Commission
Steinberg Institute
The Los Angeles Trust for Children's Health
1 Individual
OPPOSITION: (Verified 8/28/24)
None received
ARGUMENTS IN SUPPORT: According to Generation Up, “Fentanyl, an opioid that proves to be up to 50 times more intense than Heroin, is one of the overarching drugs driving the rate of drug-related overdoses in California and the United States. When laced, fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, Naloxone, which is available to purchase over-the-counter, can help counteract its effects. There has been an alarming change in the opioid epidemic, which remains a critical public health issue in California. Synthetic opioids, including fentanyl, have significantly contributed to the surge in drug-related overdose deaths. As reported by the California Department of Public Health, the state of California carries a total of 7,000 opioid-related deaths, with Fentanyl being the culprit of 88% of the deaths. SB 997 calls for the implementation of measures to deter the rising rate of opioid-related deaths among middle school and high school students. If students are engaging in drugs, the focus is to ensure safe use that avoids potential death from substance use."
Click here to enter text.
Prepared by: Kordell Hampton / ED. / (916) 651-4105
8/28/24 22:09:22
**** END ****
SENATE THIRD READING
STR Bill Id:SB 997
Author:(Portantino)
As Amended Ver:August 22, 2024
Majority vote
SUMMARY
Prohibit local educational agencies (LEAs) from prohibiting students in middle schools, junior high schools, high schools, or adult schools, from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose while on a schoolsite or while participating in school activities.
Major Provisions
- Prohibit LEAs from prohibiting students in middle schools, junior high schools, high schools, or adult schools from carrying fentanyl test strips or a federally approved opioid antagonist for over-the-counter use for the emergency treatment of persons suffering from an opioid overdose, while on a schoolsite or while participating in school activities.
- Defines LEA as a school district, county office of education (COE), or charter school.
COMMENTS
Fentanyl test strips. According to the Centers for Disease Control (CDC), fentanyl test strips are a low-cost method of helping prevent drug overdoses and reducing harm. The strips are small pieces of paper that can detect the presence of fentanyl in all different kinds of drugs (cocaine, methamphetamine, heroin, etc.) and drug forms (pills, powder, and injectables). They provide people who use drugs and communities with important information about fentanyl in the illicit drug supply so they can take steps to reduce the risk of overdose.
According to the California Department of Public Health (CDPH), fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California's syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
According to the Author
"Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose more efficiently while changing the culture of drug use to be one that is focused on harm reduction."
Arguments in Support
Generation Up writes, "Generation Up is committed to student safety, and the explosion in youth opioid overdoses is a serious threat to student well-being. Equipping and empowering students to identify potential threats and to deliver care in emergency situations may mean the difference between life and death.
Fentanyl, an opioid that proves to be up to 50 times more intense than Heroin, is one of the overarching drugs driving the rate of drug-related overdoses in California and the United States. When laced, fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, Naloxone, which is available to purchase over-the-counter, can help counteract its effects.
There has been an alarming change in the opioid epidemic, which remains a critical public health issue in California. Synthetic opioids, including fentanyl, have significantly contributed to the surge in drug-related overdose deaths. As reported by the California Department of Public Health, the state of California carries a total of 7,000 opioid-related deaths, with Fentanyl being the culprit of 88% of the deaths. SB 997 calls for the implementation of measures to deter the rising rate of opioid-related deaths among middle school and high school students. If students are engaging in drugs, the focus is to ensure safe use that avoids potential death from substance use."
Arguments in Opposition
None on file
FISCAL COMMENTS
Unknown
VOTES
SENATE FLOOR: 37-0-3
YES: Alvarado-Gil, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
ABS, ABST OR NV: Allen, Archuleta, Newman
ASM EDUCATION: 7-0-0
YES: Muratsuchi, Addis, Alvarez, Bonta, Flora, Hoover, McCarty
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Sanchez, Arambula, Bryan, Calderon, Wendy Carrillo, Dixon, Mike Fong, Grayson, Haney, Hart, Pellerin, Ta, Villapudua
ABS, ABST OR NV: Jim Patterson
UPDATED
VERSION: August 22, 2024
CONSULTANT: Debbie Look / ED. / (916) 319-2087 FN: 0004491
SENATE THIRD READING
STR Bill Id:SB 997
Author:(Portantino)
As Amended Ver:June 17, 2024
Majority vote
SUMMARY
Requires all middle schools, junior high schools, high schools, and adult schools to stock and distribute fentanyl test strips, as needed. Also authorizes a local educational agency (LEA) to develop and adopt a policy that allows students to carry a federally approved opioid antagonist for the emergency treatment of a person suffering an opioid overdose.
Major Provisions
- Requires middle schools, junior high schools, high schools, and adult schools operated by an LEA to:
- Stock fentanyl test strips in a secured location and distribute the fentanyl test strips to students as needed. Written instructions on how to properly use the fentanyl test strips are to be distributed together with the fentanyl test strips;
- Notify students of the presence and location of fentanyl test strips at least once per school year using existing means of communication; and
- Allow students to carry fentanyl test strips.
- Authorizes LEAs to develop and adopt policies that allow students in middle school, junior high schools, high schools, and adult schools to carry a federally approved opioid antagonist for the emergency treatment of a person suffering an opioid overdose.
- Requires an LEA that adopts such a policy to include a requirement that a student carrying an opioid antagonist has received instruction in the administration of the opioid antagonist.
COMMENTS
Fentanyl test strips. According to the Centers for Disease Control (CDC) fentanyl test strips are a low-cost method of helping prevent drug overdoses and reducing harm. The strips are small pieces of paper that can detect the presence of fentanyl in all different kinds of drugs (cocaine, methamphetamine, heroin, etc.) and drug forms (pills, powder, and injectables). They provide people who use drugs and communities with important information about fentanyl in the illicit drug supply so they can take steps to reduce the risk of overdose.
According to the California Department of Public Health (CDPH), fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California's syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within five minutes.
One small pilot study of young adults aged 18-35 years with self-reported drug use was designed to understand the impacts of using take home fentanyl test strips for personal use over a four-week period. The majority of participants (87%) found the strips useful and straightforward to use. Positive results led some to alter their drug use behaviors, including discarding their drug supply. The authors concluded that given the high level of acceptability and behavioral changes reported by study participants, the provision of test strips may be a useful harm reduction intervention to reduce fentanyl overdose. (Goldman, 2019)
According to the Author
"Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose more efficiently while changing the culture of drug use to be one that is focused on harm reduction."
Arguments in Support
Generation Up, a co-sponsor writes, "Generation Up is committed to student safety, and the explosion in youth opioid overdoses is a serious threat to student well-being. Equipping and empowering students to identify potential threats and to deliver care in emergency situations may mean the difference between life and death.
Fentanyl, an opioid that proves to be up to 50 times more intense than Heroin, is one of the overarching drugs driving the rate of drug-related overdoses in California and the United States. When laced, fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, Naloxone, which is available to purchase over-the-counter, can help counteract its effects.
There has been an alarming change in the opioid epidemic, which remains a critical public health issue in California. Synthetic opioids, including fentanyl, have significantly contributed to the surge in drug-related overdose deaths. As reported by the California Department of Public Health, the state of California carries a total of 7,000 opioid-related deaths, with Fentanyl being the culprit of 88% of the deaths. SB 997 calls for the implementation of measures to deter the rising rate of opioid-related deaths among middle school and high school students. If students are engaging in drugs, the focus is to ensure safe use that avoids potential death from substance use."
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Assembly Appropriations Committee:
- Ongoing Proposition 98 General Fund costs, of an unknown amount, potentially in the hundreds of thousands of dollars to low millions of dollar annually, to LEAs to stock and distribute fentanyl strips. The state has about 3,000 middle schools and high schools and about 2.3 million students. If schools provided 10% of students with one fentanyl strip annually, costs would be $230,000. If schools provided 25% of students with two fentanyl strips annually, costs would be $1.2 million. Costs ultimately would depend on student demand for the strips.
- Ongoing Proposition 98 General Fund costs, of an unknown but likely minor amount, for LEAs to notify students of the presence and location of fentanyl test strips at least once per school year using existing means of communication. Costs would depend on how LEAs opt to notify students.
- One-time Proposition 98 General Fund cost pressures, of an unknown amount, potentially in the hundreds of thousands of dollars, to LEAs that elect to develop policies to allow students to carry a federally approved opioid antagonist. This bill could also result in additional ongoing cost pressures for these LEAs to require students carrying an antagonist to receive instruction in the administration of the antagonist. Costs would depend on the number of LEAs electing to develop a policy.
- If the Commission on State Mandates determines the bill's requirements to be a reimbursable state mandate, the state would need to reimburse these costs to LEAs or provide funding through the K-12 Mandate Block Grant.
VOTES
SENATE FLOOR: 37-0-3
YES: Alvarado-Gil, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
ABS, ABST OR NV: Allen, Archuleta, Newman
ASM EDUCATION: 7-0-0
YES: Muratsuchi, Addis, Alvarez, Bonta, Flora, Hoover, McCarty
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Sanchez, Arambula, Bryan, Calderon, Wendy Carrillo, Dixon, Mike Fong, Grayson, Haney, Hart, Pellerin, Ta, Villapudua
ABS, ABST OR NV: Jim Patterson
UPDATED
VERSION: June 17, 2024
CONSULTANT: Debbie Look / ED. / (916) 319-2087 FN: 0003950
Date of Hearing: July 2, 2024
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
SBPCA Bill Id:SB 997
Author:(Portantino) – As Amended Ver:June 17, 2024
Policy Committee: | Education | Vote: | 7 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: Yes
SUMMARY:
This bill requires all middle schools, high schools, and adult schools to stock and distribute fentanyl test strips, as needed.
This bill also authorizes a local educational agency (LEA) to develop and adopt a policy that allows certain students to carry a federally approved opioid antagonist for the emergency treatment of a person suffering an opioid overdose.
Specifically, this bill requires middle schools, high schools, and adult schools operated by an LEA to:
- Stock fentanyl test strips in a secured location and distribute the fentanyl test strips to students as needed. Written instructions on how to properly use the fentanyl test strips are to be distributed together with the fentanyl test strips.
- Notify students of the presence and location of fentanyl test strips at least once per school year using existing means of communication.
- Allow students to carry fentanyl test strips.
The bill also authorizes LEAs to develop and adopt a policies that allow students in middle school, high schools, and adult schools to carry a federally approved opioid antagonist for the emergency treatment of a person suffering an opioid overdose. The bill requires an LEA that adopts a policy to include a requirement that a student carrying an antagonist has received instruction in the administration of the antagonist.
FISCAL EFFECT:
- Ongoing Proposition 98 General Fund costs, of an unknown amount, potentially in the hundreds of thousands of dollars to low millions of dollar annually, to LEAs to stock and distribute fentanyl strips.
The state has about 3,000 middle schools and high schools and about 2.3 million students. If schools provided 10% of students with one fentanyl strip annually, costs would be $230,000. If schools provided 25% of students with two fentanyl strips annually, costs would be $1.2 million. Costs ultimately would depend on student demand for the strips.
- Ongoing Proposition 98 General Fund costs, of an unknown but likely minor amount, for LEAs to notify students of the presence and location of fentanyl test strips at least once per school year using existing means of communication. Costs would depend on how LEAs opt to notify students.
- One-time Proposition 98 General Fund cost pressures, of an unknown amount, potentially in the hundreds of thousands of dollars, to LEAs that elect to develop policies to allow students to carry a federally approved opioid antagonist. This bill could also result in additional ongoing cost pressures for these LEAs to require students carrying an antagonist to receive instruction in the administration of the antagonist. Costs would depend on the number of LEAs electing to develop a policy.
If the Commission on State Mandates determines the bill’s requirements to be a reimbursable state mandate, the state would need to reimburse these costs to LEAs or provide funding through the K-12 Mandate Block Grant.
According to the Legislative Analyst’s Office, the General Fund faces a structural deficit in the tens of billions of dollars over the next several fiscal years.
COMMENTS:
- Background. Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine. Recent cases of fentanyl-related overdoses are linked to illicitly manufactured fentanyl that is distributed through illegal drug markets and sometimes added to counterfeit pills. According to Center for Disease Control, “a fentanyl strip is a low-cost method of helping prevent drug overdoses and reducing harm. Fentanyl strips are small strips of paper that can detect the presence of fentanyl in all different kinds of drugs (cocaine, methamphetamine, heroin, etc.) and drug forms (pills, powder, and injectables).” The strips can be purchased from several vendors and businesses and cost approximately $1 each. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
This bill requires middle schools, high schools, and adult schools to stock fentanyl strips.
- Related Legislation. AB 461 (Ramos), Chapter 525, Statutes of 2023, requires the governing board of each community college district and the Trustees of the California State University to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips.
SB 10 (Cortese), Chapter 856, Statutes of 2023, requires school safety plans of schools, including charter schools, serving students in grades seven through 12 to include a protocol for responding to a student's opioid overdose; and requires the California Department of Education to post informational materials on its website on opioid overdose prevention, among other provisions.
Analysis Prepared by: Natasha Collins / APPR. / (916) 319-2081
Date of Hearing: June 12, 2024
ASSEMBLY COMMITTEE ON EDUCATION
Al Muratsuchi, Chair
SBPCA Bill Id:SB 997
Author:(Portantino) – As Amended Ver:April 8, 2024
SENATE VOTE: 37-0
SUBJECT: Pupil health: opioid antagonists and fentanyl test strips
SUMMARY: Authorizes local educational agencies (LEAs) to adopt a policy allowing students to carry a federally approved opioid antagonist, and requires that if a policy is adopted it include a requirement that a student has received instruction in the administration of an opioid antagonist; requires schools to stock fentanyl test strips and to distribute the test strips as needed as well as written instructions on their use and requires schools to allow students to carry the test strips. Specifically, this bill:
- Requires middle schools, junior high schools, high schools, and adult schools operated by LEAs to:
- Stock fentanyl test strips in a secured location and distribute the test strips as needed;
- Provide written instructions on how to properly use the test strips when distributing the test strips;
- Notify students of the presence and location of the fentanyl test strips; and
- Allow students to carry fentanyl test strips on their person or their personal property.
- Authorizes LEAs to develop and adopt a policy that allows students in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal product or any other federally approved opioid antagonist for over-the-counter, nonprescription use for the emergency treatment of persons suffering from an opioid overdose.
- Requires, if an LEA adopts a policy pursuant to (2), that the policy include a requirement that a student has received instruction in the administration of the opioid antagonist.
- Defines “local educational agency” as a school district, county office of education (COE), or charter school.
EXISTING LAW:
- Authorizes school districts, COEs, and charter schools to provide emergency naloxone hydrochloride or another opioid antagonist to school nurses or trained volunteer personnel for the purpose of providing emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose. (Education Code (EC) 49414.3)
- Requires that the comprehensive school safety plan developed by school districts and COEs enrolling students in grades 7 to 12 include a protocol in the event a student is suffering or reasonably believed to be suffering from an opioid overdose. (EC 32282)
- Requires the school safety plan developed by charter schools enrolling students in grades 7 to 12 include a protocol in the event a student is suffering or reasonably believed to be suffering from an opioid overdose. (EC 47605 and 47605.6)
- Encourages COEs to establish a County Working Group on Fentanyl Education in Schools for outreach, building awareness, and collaborating with local health agencies regarding fentanyl overdoses, and encourages the working group to include representatives of LEAs within the county as well as the county public health department. Also requires the California Department of Education (CDE) to curate and maintain on its website, informational materials containing awareness and safety advice on how to prevent an opioid overdose. (EC 49428.16)
- Authorizes a student to be suspended or recommended for expulsion if it is determined that the student has, among other offenses, unlawfully possessed, used, sold, or otherwise furnished, or been under the influence of a controlled substance, an alcoholic beverage, or an intoxicant of any kind, or has unlawfully possessed or unlawfully offered, arranged, or negotiated to sell drug paraphernalia, as defined. (EC 48900)
- Defines “drug paraphernalia” as all equipment, products, and materials which are designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance, including testing equipment designed for use in identifying or analyzing the strength, effectiveness, or purity of controlled substances. (Health and Safety Code (HSC) 11014.5)
- Authorizes a pharmacy to furnish naloxone hydrochloride or another opioid antagonist to a school district, COE, or charter school provided that the naloxone hydrochloride or another opioid antagonist is for use exclusively at the school site and if a physician provides a written order that specifies the quantity of the opioid antagonist that is to be furnished. (Business and Professions Code (BPC) 4119.8)
FISCAL EFFECT: According to the Senate Appropriations Committee:
- This bill could result in a reimbursable state mandate for LEAs to stock and distribute fentanyl test strips. Depending on the number of test strips that LEAs elect to purchase, statewide Proposition 98 General Fund costs could be in the low millions of dollars each year. The actual cost will vary by LEA and could decrease over time depending on the demand for test strips.
- This bill could result in additional costs for LEAs that elect to develop and adopt policies on the use of naloxone. The costs will vary by LEA but could be in the hundreds of thousands of dollars statewide on a one-time basis (Proposition 98 General Fund). This bill could also result in additional, unknown local cost pressures for LEAs to provide instruction to students on the policies.
COMMENTS:
Need for the bill. According to the author, “Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose more efficiently while changing the culture of drug use to be one that is focused on harm reduction.”
Dangers associated with Fentanyl. Fentanyl is a potent synthetic opioid drug approved by the Food and Drug Administration (FDA) for use as an analgesic and anesthetic. It is approximately 50 times stronger than heroin and 100 times stronger than morphine. First developed in 1959, it was introduced in the 1960s as an intravenous anesthetic. Fentanyl is legally manufactured and distributed in the United States; however, there are two types of fentanyl: pharmaceutical fentanyl and illicitly manufactured fentanyl. Both are considered synthetic opioids.
Pharmaceutical fentanyl is prescribed by doctors to treat severe pain, especially after surgery, and for advanced-stage cancer. Most recently, cases of fentanyl-related overdoses have been linked to illicitly manufactured fentanyl that is distributed through illegal drug markets for its heroin-like effect. It is often added to other drugs because of its extreme potency, which makes drugs cheaper, more powerful, more addictive, and more dangerous.
Addressing Fentanyl Among California Youth. According to the California Department of Public Health (CDPH), there were 6,000 opioid-related overdose deaths in California in 2021. CDPH also reports that fentanyl-related overdose deaths increased by 625% among young people aged 10-19 years from 2018 to 2020, and there were 177 fentanyl-related overdose deaths and 1,165 opioid-related overdose emergency department visits among youth ages 10-19 years old in 2022.
Current law requires the Superintendent of Public Instruction (SPI) to establish minimum training standards for school employees who volunteer to administer naloxone hydrochloride or another opioid antagonist. In addition to setting minimum training standards, the CDE must maintain on its website a clearinghouse for best practices in training nonmedical personnel to administer naloxone hydrochloride or another opioid antagonist to pupils.
The CDE, in conjunction with the CDPH, has developed resources and information that LEAs can readily share with parents and students to help keep them safe. The Fentanyl Awareness and Prevention webpage offers information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
Reversing opioid overdoses. Naloxone hydrochloride is the generic name for an opioid antagonist that rapidly reverses an opioid overdose. It attaches to opioid receptors and reverses and blocks the effects of other opioids. Naloxone hydrochloride can quickly restore normal breathing to a person if their breathing has slowed or stopped because of an opioid overdose. Naloxone hydrochloride comes in two FDA-approved forms: injectable and prepackaged nasal spray.
In July 2023, the Food and Drug Administration (FDA) approved Narcan and RiVive for over-the-counter (OTC) nonprescription use. These are the first naloxone hydrochloride products approved for use without a prescription. This approval will allow the medications to be sold directly to consumers in drug stores, grocery stores, as well as online. According to an FDA Commissioner, “The approval of OTC naloxone hydrochloride nasal spray will help improve access to naloxone hydrochloride, increase the number of locations where it is available and help reduce opioid overdose deaths throughout the country. We encourage the manufacturer to make accessibility to the product a priority by making it available as soon as possible and at an affordable price.”
Fentanyl test strips. The Centers for Disease Control (CDC) website states that fentanyl test strips are a low-cost method of helping prevent drug overdoses and reducing harm. The strips are small pieces of paper that can detect the presence of fentanyl in all different kinds of drugs (cocaine, methamphetamine, heroin, etc.) and drug forms (pills, powder, and injectables). They provide people who use drugs and communities with important information about fentanyl in the illicit drug supply so they can take steps to reduce the risk of overdose.
According to the CDPH website, fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California’s syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
One small pilot study of young adults aged 18-35 years with self-reported drug use was designed to understand the impacts of using take home fentanyl test strips for personal use over a 4-week period. The majority of participants (87%) found the strips useful and straightforward to use. Positive results led some to alter their drug use behaviors, including discarding their drug supply. The authors concluded that given the high level of acceptability and behavioral changes reported by study participants, the provision of test strips may be a useful harm reduction intervention to reduce fentanyl overdose. (Goldman, 2019)
Naloxone Distribution Project. A distribution program administered through the Department of Health Care Services (DHCS), the Naloxone Distribution Project (NDP) allows various entities, including schools, universities, and colleges, to apply for and obtain naloxone hydrochloride at no cost to the institution. As of February 20, 2024, the NDP has approved more than 10,800 applications for naloxone hydrochloride (17% of which are from schools and universities), distributed more than 3.8 million kits of naloxone hydrochloride and reversed more than 245,000 opioid overdoses. DHCS reports that less than 1% of the overdose reversals reported in the NDP occurred in schools and universities.
Some California school districts have opted to make naloxone hydrochloride available. The Los Angeles Unified School District (LAUSD), the state’s largest school district, announced plans to stock naloxone hydrochloride at over 1,400 elementary, middle, and high schools in response to numerous incidents of students experiencing overdoses, including at least one death in 2022. San Diego Unified School District, the state’s second-largest school system, stocks naloxone hydrochloride at schools with students in sixth grade or higher. Since 2020, Elk Grove Unified School District has provided naloxone hydrochloride to school security officers and their supervisors. In Los Angeles County, the Palos Verdes Peninsula Unified School District trained all the district’s registered nurses on how to administer naloxone hydrochloride and made it available to them at that district’s high schools.
Recommended Committee Amendments. Staff recommend that the bill be amended as follows:
- Remove reference to “a federally approved naloxone hydrochloride nasal product or any other federally approved opioid antagonist for over-the-counter, nonprescription use” and replace with “a federally approved opioid antagonist for over-the-counter use.”
- Clarify that fentanyl test strips may be distributed to pupils.
- Specify that the requirement to notify pupils of the presence and location of fentanyl test strips shall be conducted by existing means of communication with pupils at least once per year.
Arguments in support. Generation Up, a co-sponsor writes, “Generation Up is committed to student safety, and the explosion in youth opioid overdoses is a serious threat to student well-being. Equipping and empowering students to identify potential threats and to deliver care in emergency situations may mean the difference between life and death.
Fentanyl, an opioid that proves to be up to 50 times more intense than Heroin, is one of the overarching drugs driving the rate of drug-related overdoses in California and the United States. When laced, Fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, Naloxone, which is available to purchase over-the-counter, can help counteract its effects.
There has been an alarming change in the opioid epidemic, which remains a critical public health issue in California. Synthetic opioids, including Fentanyl, have significantly contributed to the surge in drug-related overdose deaths. As reported by the California Department of Public Health, the state of California carries a total of 7,000 opioid-related deaths, with Fentanyl being the culprit of 88% of the deaths. SB 997 calls for the implementation of measures to deter the rising rate of opioid-related deaths among middle school and high school students. If students are engaging in drugs, the focus is to ensure safe use that avoids potential death from substance use.”
Related legislation. AB 2998 (McKinnor) of the 2023-24 Session would prohibit school districts, COEs, and charter schools, from preventing a student from carrying or administering an opioid reversal medication.
AB 461 (Ramos), Chapter 525, Statutes of 2023, requires the governing board of each community college district and the Trustees of the California State University to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
AB 3271 (Joe Patterson) of the 2023-24 Session would have required each public school that has chosen to permit school nurses or voluntarily trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering from an opioid overdose, to maintain at least two units of naloxone hydrochloride or another opioid antagonist on its site. This bill was held in the Assembly Appropriations Committee.
AB 1915 (Arambula) of the 2023-24 Session would have required the CDPH to develop, by July 1, 2026, a training program and toolkit for public school students in grades nine to 12, to gain skills in how to identify and respond to an opioid overdose, including the administering of a federally approved opioid overdose reversal medication. This bill was held in the Assembly Appropriations Committee.
SB 10 (Cortese), Chapter 856, Statutes of 2023, adds to the list of requirements for a comprehensive school safety plan, a protocol in the event a pupil is suffering or is reasonably believed to be suffering from an opioid overdose.
AB 889 (Joe Patterson), Chapter 123, Statutes of 2023, requires a school district, COE, and charter school to annually inform parents or guardians of the dangers associated with using synthetic drugs at the beginning of the first semester or quarter of the regular school term and to post this information on their websites.
AB 19 (Joe Patterson) of the 2023-24 Session would have required public schools to maintain at least two doses of naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to a person suffering from an opioid overdose. This bill was held in the Senate Appropriations Committee.
SB 472 (Hurtado) of the 2023-24 Session would have required each campus of a public school operated by an LEA, COE, or charter school to maintain at least two doses on its campus, and distribute naloxone hydrochloride or another opioid antagonist pursuant to the standing order for naloxone hydrochloride and would have required LEAs, COEs, and charter schools to report to the DHCS for failure to distribute naloxone hydrochloride. This bill was held in the Senate Appropriations Committee.
AB 1748 (Mayes), Chapter 557, Statutes of 2016, authorizes school nurses and other trained personnel to use naloxone hydrochloride or another opioid antagonist to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an opioid overdose.
REGISTERED SUPPORT / OPPOSITION:
Support
Alameda County Office of Education
American Academy of Pediatrics, California
California Association of Alcohol and Drug Program Executives
California State PTA
California Youth Empowerment Network
City and County of San Francisco
Generation Up
Mental Health America of California
Napnap California
San Francisco Youth Commission
Steinberg Institute
Opposition
None on file
Analysis Prepared by: Debbie Look / ED. / (916) 319-2087
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SB 997 |
THIRD READING
Bill No: SB 997
Author: Portantino (D), et al.
Amended: 4/8/24
Vote: 21
SENATE EDUCATION COMMITTEE: 7-0, 3/20/24
AYES: Newman, Ochoa Bogh, Cortese, Glazer, Gonzalez, Smallwood-Cuevas, Wilk
SENATE HEALTH COMMITTEE: 11-0, 4/22/24
AYES: Roth, Nguyen, Glazer, Gonzalez, Grove, Hurtado, Limón, Menjivar, Rubio, Smallwood-Cuevas, Wiener
SENATE APPROPRIATIONS COMMITTEE: 7-0, 5/16/24
AYES: Caballero, Jones, Ashby, Becker, Bradford, Seyarto, Wahab
SUBJECT: Pupil health: opioid antagonists and fentanyl test strips
SOURCE: Author
DIGEST:
This bill permits local educational agencies (LEAs) to develop and adopt a policy that allows pupils at certain schools to carry over-the-counter (OTC), nonprescription naloxone, and/or fentanyl testing strips as specified. Requires those schools to stock and distribute fentanyl test strips, as specified.
ANALYSIS:
Existing law:
Education Code (EC)
- Requires the governing board of each community college district (CCD) and the Trustees of the California State University (CSU), and requests the Regents of the University of California (UC), to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center. (EC § 67384)
- Requires COEs, among other requirements, to be eligible for funds to purchase at least two units for each middle school, junior high school, high school, and adult school schoolsite within their jurisdiction, but are not required to participate. (EC § 49414.8)
- Requires an LEA that serve pupils in any of grades 7 to 12, to include in their school safety plan, a protocol in the event a pupil is suffering or is reasonably believed to be suffering from an opioid overdose. (EC § 32282(K))
- Permits a school nurse or trained personnel who has volunteered to provide emergency naloxone or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose. (EC § 49414.3(a))
- Requires an LEA, COE, or charter school electing to utilize naloxone or another opioid antagonist for emergency aid to ensure that each employee who volunteers are provided defense and indemnification by the LEA, COE, or charter school for any and all civil liability. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file. (EC § 49414.3(i))
- Provides a school no more than two weeks to restock their supply of naloxone or another opioid antagonist after use. (EC § 49414.3(h)
Civil Code (CIV)
- Permits a licensed health care provider who is authorized by law to prescribe an opioid antagonist to issue standing orders for the distribution of an opioid antagonist to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist a person at risk of an opioid-related overdose. (CIV § 1714.22 et. sq.)
This bill:
- Authorizes an LEA to develop and adopt a policy, that at a minimum requires that the pupil has received instruction on how to administer naloxone, which allows pupils in middle schools and high schools to carry federally approved naloxone to use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
- Authorizes an LEA to develop and adopt a policy, that allows pupils in middle schools and high schools to carry fentanyl testing strips.
- Require an LEA to do the following for middle and high schools with in their jurisdiction:
- Stock and distribute fentanyl test strips in a secured location along with written instructions on how to properly use the fentanyl test strips.
- Notify pupils of the presence and location of fentanyl test strips.
- Defines “LEA” as a school district, county office of education, or charter school.
Comments
- Need for the bill. According to the author, “It is nearly impossible to tell if drugs have been laced with fentanyl unless you test your drugs with testing strips. Drug testing strips still hold a negative association with drug use, thereby stigmatizing this lifesaving tool. If we want to help our young people, we must take steps that preserve their livelihood. Test strips are inexpensive and typically give results within 5 minutes, which can be the difference between life or death. Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry with live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose faster.”
- Addressing Fentanyl Among California Youth. Pursuant to AB 1748 (Mayes, Chapter 557, Statutes of 2016), among other things, requires the Superintendent of Public Instruction is required to establish minimum training standards for school employees who volunteer to administer naloxone or another opioid antagonist. In addition to setting minimum training standards, the CDE must maintain on its website a clearinghouse for best practices in training nonmedical personnel to administer naloxone or another opioid antagonist to pupils.
The CDE, in conjunction with the California Department of Public Health (CDPH), provides LEAs with resources and information that they can readily share with parents and students to help keep them safe. The shareable Fentanyl Awareness and Prevention toolkit page offer information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
While schools are authorized but not required to stock naloxone, some LEAs and COEs have also adjusted to address this growing crisis. For example, the Lake County Office of Education and Washington Unified School District in West Sacramento recently implemented a local school naloxone policy consistent with state statutes (which requires school employees who elect to administer naloxone, to be trained in the administration, and to keep the naloxone stocked and stored appropriately). San Diego Unified School District created its naloxone toolkit to aid other LEAs and inform parents and guardians.
Further, the legislature has adopted a series of legislation such as SB 10 (Cortese, Chapter 856, Statutes of 2023), which requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023) that, among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists, with the intent that it complement efforts of the Naloxone Distribution Project; and AB 889 (Joe Patterson, Chapter 123, Statutes of 2023) which required LEA, COE, and charter school to annually inform parents or guardians of the dangers associated with using synthetic drugs and post this information on their respective internet websites.
- Statewide Standing Order for Naloxone. Naloxone can help reduce opioid overdose deaths in California, but many organizations find it challenging to obtain the required standing order to get naloxone from healthcare providers. CDPH issued the standing order in 2017 to address this need and support equitable naloxone access. The standing order:
- Allows community organizations and other non-prescribing entities (organizations that do not employ or contract with a medical provider that has a license to prescribe and can issue a standing order and provide oversight for the distribution and administration of naloxone) in California that are not currently working with a physician to distribute naloxone to a person at risk of an opioid-related overdose or to a family member, friend, or another person in a position to assist; and
- Allows for the administration of naloxone by a family member, friend, or other person to a person experiencing or reasonably suspected of experiencing an opioid overdose.
Among the organizations and entities that can distribute naloxone under the order are colleges and universities. An individual at risk of experiencing an overdose or someone who can assist an individual at risk is allowed to do so. Under the statewide standing order, staff of community organizations and other entities distributing naloxone must be trained. They are also required to provide training to individuals who receive naloxone from them. Colleges, schools, and other organizations may apply to use the statewide standing order if they meet certain conditions.
- The U.S. Food and Drug Administration: Approval of Over-The-Counter Naloxone. On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.
The FDA first approved naloxone nasal spray in 2015 as a prescription drug. In accordance with a process to change the status of a drug from prescription to nonprescription, the manufacturer provided data demonstrating that the drug is safe and effective for use as directed in its proposed labeling. The manufacturer also showed that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional. The application to approve naloxone nasal spray for OTC use was granted priority review status and was the subject of an advisory committee meeting in February 2023, where committee members voted unanimously to recommend it be approved for marketing without a prescription.
On July 28, 2023, the FDA approved RiVive, a (3mg) naloxone nasal spray for OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription.
- Naloxone: Training Requirements. Civil Code 1714.22 requires a person who is prescribed or possesses an opioid antagonist, pursuant to the standing order, to receive training provided by an opioid overdose prevention and treatment training program (CIV 1714.22 (d)). This includes learning the causes of an opiate overdose, mouth-to-mouth resuscitation, how to contact appropriate emergency medical services, and how to administer an opioid antagonist (CIV 1714.22 (a)(2)). While CDPH makes opioid reversal medication training available online through its website, current statute does not require an individual who purchases OTC opioid reversal medication to receive training.
- Are There Other Training Programs Available? The American Red Cross provides a First Aid for Opioid Overdoses Online course that teaches persons to identify the signs and symptoms of a suspected opioid overdose and then the appropriate care to provide based on the responsiveness of the person. This course includes information on how to use several different naloxone products -- a nasal atomizer, Narcan and EVZIO -- to reverse the effects of an opioid overdose. According to the American Red Cross website, this “interactive course includes audio and video and takes approximately 45 minutes to complete. [A person] must pass a final quiz to complete the course.” The American Red Cross provides this online training for $20.
- Fentanyl test strips. According to CDPH’s website, fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California’s syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee analysis, “This bill could result in a reimbursable state mandate for LEAs to stock and distribute fentanyl test strips. Depending on the number of test strips that LEAs elect to purchase, statewide Proposition 98 General Fund costs could be in the low millions of dollars each year. The actual cost will vary by LEA and could decrease over time depending on the demand for test strips. This bill could result additional costs for LEAs that elect to develop and adopt policies on the use of naloxone. The costs will vary by LEA but could be in the hundreds of thousands of dollars statewide on a one-time basis (Proposition 98 General Fund). This bill could also result in additional, unknown local cost pressures for LEAs to provide instruction to students on the policies.
SUPPORT: (Verified 5/16/24)
Alameda County Office of Education
American Academy of Pediatrics, California
California Association of Alcohol and Drug Program Executives
California State PTA
California Youth Empowerment Network
Generation Up
Mental Health America of California
National Association of Pediatric Nurse Practitioners, California
Steinberg Institute
1 individual
OPPOSITION: (Verified 5/16/24)
None received
ARGUMENTS IN SUPPORT: According to the Alameda County Office of Education, “Fentanyl is one of the drugs driving the rate of drug-related overdoses in California and the United States. When laced, fentanyl is undetectable, unless a fentanyl test strip is utilized. SB 997 calls for the implementation of measures to deter the rising rate of opioid related deaths among middle school and high school students. The bill would increase student access to opioid antagonists and to fentanyl testing strips, both strong preventative approaches for opioid-related deaths. For the above reasons, ACOE respectfully urges your support for SB 997.”
Click here to enter text.
Prepared by: Kordell Hampton / ED. / (916) 651-4105
5/17/24 18:48:58
**** END ****
SENATE COMMITTEE ON
Senator Anna Caballero, Chair
2023 - 2024 Regular Session
SB 997 (Portantino) - Pupil health: opioid antagonists and fentanyl test strips
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
This bill would require middle, junior high, adult and high schools operated by a local education agency (LEA) to stock and distribute fentanyl test strips. This bill would also authorize LEAs, county offices of education (COE), and charter schools to develop and adopt a policy that allows pupils in middle schools and high schools to carry federally approved naloxone hydrochloride (naloxone).
Fiscal Impact:
- This bill could result in a reimbursable state mandate for LEAs to stock and distribute fentanyl test strips. Depending on the number of test strips that LEAs elect to purchase, statewide Proposition 98 General Fund costs could be in the low millions of dollars each year. The actual cost will vary by LEA and could decrease over time depending on the demand for test strips.
- This bill could result additional costs for LEAs that elect to develop and adopt policies on the use of naloxone. The costs will vary by LEA but could be in the hundreds of thousands of dollars statewide on a one-time basis (Proposition 98 General Fund). This bill could also result in additional, unknown local cost pressures for LEAs to provide instruction to students on the policies.
Background:
Existing law permits a school nurse or trained personnel who have volunteered to provide emergency naloxone hydrochloride or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose.
Existing law provides a school no more than two weeks to restock their supply of naloxone hydrochloride or another opioid antagonist after use. It also requires an LEA electing to utilize naloxone hydrochloride or another opioid antagonist for emergency aid to ensure that each employee who volunteers are provided defense and indemnification for any and all civil liability. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file.
Proposed Law:
This bill authorizes an LEA to develop and adopt a policy that allows pupils in middle, junior high, adult and high schools to carry federally approved naloxone to use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
This bill require an LEA to do the following for middle and high schools with in their jurisdiction: stock and distribute fentanyl test strips in a secured location along with written instructions on how to properly use the fentanyl test strips; and notify pupils of the presence and location of fentanyl test strips.
This bill provides that the polices adopted by LEAs, COEs, and charter schools shall include, at a minimum, instruction for students who elect to carry naloxone on school campus. The bill also allows for any federally approved naloxone to be carried on school campus by student.
Related Legislation:
AB 461 (Ramos, Chapter 525, Statutes of 2023) requires the governing board of each CCD and the Trustees of the CSU to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
SB 10 (Cortese, Chapter 856, Statutes of 2023) requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; requires the California Department of Education (CDE) to post informational materials on its website on opioid overdose prevention; and encourages COEs to establish working groups on fentanyl education in schools.
Staff Comments:
This bill could result in a reimbursable state mandate for LEAs to stock and distribute fentanyl test strips. According to the California Department of Public Health, fentanyl test strips are a harm reduction strategy. The strips can be purchased from several vendors and businesses and cost approximately $1 each. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
This bill defines LEA as county offices of education, school districts, state special schools, and charter schools. To the extent it took 5 hours of staff time for each school district and county office of education that elects to develop and adopt a policy on the use of naloxone, one-time costs would be approximately $375,000. There could also be additional, unknown local cost pressures for LEAs to provide instruction to students.
-- END --
SENATE COMMITTEE ON HEALTH
Senator Richard Roth, Chair
BILL NO: SB 997
AUTHOR: | Portantino | ||
VERSION: | April 8, 2024 | ||
HEARING DATE: | April 22, 2024 | ||
CONSULTANT: | Reyes Diaz | ||
SUBJECT: Pupil health: opioid antagonists and fentanyl test strips
SUMMARY:
Permits local educational agencies to develop and adopt a policy that allows pupils at certain schools to carry over-the-counter (OTC), nonprescription naloxone, as specified. Requires those schools to stock and distribute fentanyl test strips, as specified.
Existing law:
- Authorizes licensed health care providers to issue a standing order for the distribution or the administration of naloxone to a person at risk of overdose, or family members, friends, or other persons in a position to assist a person at risk of an opioid-related overdose. Requires a person who is prescribed or possesses naloxone pursuant to a standing order to receive training, as specified. [CIV §1714.22, et seq.]
- Permits a school nurse or trained personnel who have volunteered to provide emergency naloxone or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose. [EDC §49414.3]
- Permits each public and private elementary and secondary school to voluntarily determine whether or not to make emergency naloxone or another opioid antagonist and trained personnel available at its school. [EDC §49414.3]
- Permits each public and private elementary and secondary school to designate one or more volunteers to receive initial and annual refresher training, as specified, regarding the storage and emergency use of naloxone or another opioid antagonist from the school nurse or other qualified person, as specified. [EDC §49414.3]
- Requires the State Superintendent to establish minimum standards of training for the administration of naloxone or another opioid antagonist, as specified. Requires the Superintendent, every five years or sooner, to review the minimum standards. [EDC §49414.3]
- Requires any school district, county office of education (COE), or charter school (known as “local educational agencies” [LEAs]) electing to utilize naloxone or another opioid antagonist for emergency aid to distribute a notice at least once per school year to all staff that contains specified information related to volunteers to administer naloxone and specified training. [EDC §49414.3]
- Requires a qualified supervisor of health at a LEA electing to utilize naloxone or another opioid antagonist for emergency aid to obtain from an authorizing physician a prescription for each school for naloxone or another opioid antagonist, and to stock the naloxone, as specified. [EDC §49414.3]
- Requires a LEA electing to utilize naloxone or another opioid antagonist for emergency aid to ensure that each employee who volunteers is provided defense and indemnification by the LEA for any and all civil liability. Requires the information to be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file. [EDC §49414.3]
This bill:
- Permits LEAs to develop and adopt a policy that allows pupils in middle schools, junior high schools, high schools, and adult schools to carry a federally approved naloxone hydrochloride nasal product or any other federally approved, over-the-counter (OTC) opioid antagonist for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
- Requires LEAs that develop and adopt a policy to include, at a minimum, a requirement that a pupil has received instruction in the administration of the naloxone product or other federally approved opioid antagonist.
- Requires middle schools, junior high schools, high schools, and adult schools operated by a LEA to do all of the following:
- Stock fentanyl test strips in a secured location and distribute them as needed, with accompanying written instructions on how to properly use them;
- Notify pupils of the presence and location of fentanyl test strips; and,
- Allow pupils to carry fentanyl test strips.
FISCAL EFFECT:
This bill has not been analyzed by a fiscal committee.
COMMENTS:
- Author’s statement. According to the author, fentanyl is a type of synthetic opioid that is practically invisible to the naked eye, making it nearly impossible to detect as it is often laced. Within schools, students who are engaging in drug use, can be susceptible to potential opioid overdose, making them a vulnerable group; therefore, SB 997 can help combat the rising rates of opioid related overdoses through mandated access to fentanyl strips and federally approved naloxone hydrochloride nasal spray. Currently, schools allow authorized personnel and school nurses access to these opioid antagonists, however, this bill urges this access to students as well.
- Naloxone and OTC approval. According to the California Department of Public Health (CDPH) website, naloxone is an opioid antagonist that works almost immediately to reverse opiate overdose and has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders, such as friends, family, and other non-health care providers, and drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose. On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved four-milligram naloxone nasal spray for OTC, nonprescription, use—the first naloxone product approved for use without a prescription. This action, according to the FDA, paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores, and gas stations, as well as online.
- Fentanyl. Fentanyl is a potent synthetic opioid drug approved by the FDA for use as an analgesic and anesthetic. It is approximately 50 times stronger than heroin and 100 times stronger than morphine. First developed in 1959, it was introduced in the 1960s as an intravenous anesthetic. Fentanyl is legally manufactured and distributed in the U.S.; however, there are two types of fentanyl: pharmaceutical fentanyl and illicitly manufactured fentanyl. Both are considered synthetic opioids. Pharmaceutical fentanyl is prescribed by doctors to treat severe pain, especially after surgery and for advanced-stage cancer. Most recently, cases of fentanyl-related overdoses are linked to illicitly manufactured fentanyl that is distributed through illegal drug markets for its heroin-like effect. It is often added to other drugs because of its extreme potency, which makes drugs cheaper, more powerful, more addictive, and more dangerous. The Centers for Disease Control and Prevention (CDC) reports that over 150 people die every day from overdoses related to synthetic opioids like fentanyl. Only three states—California, Illinois, and Virginia—experienced a statistically significant change in overdose death rates involving synthetic opioids from 2016 to 2017. Eighteen states reflected no statistically significant change in overdose deaths, and 25 states plus the District of Columbia had remained stable. In stark contrast, the 2019-2020 figures reflect that 40 states and the District of Columbia experienced a statistically significant increase in opioid related deaths, while only four states did not have a significant increase, and only seven states remained stable. According to the CDPH Opioid Overdose Dashboard, fentanyl was involved in over 83% of the 7,175 opioid-related deaths in 2021. The number of deaths each year involving fentanyl increased dramatically between 2012 and 2021. During this time period, fentanyl-related overdose deaths increased by more than 7,250%, from 82 in 2012 to 5,961 in 2021.
- Fentanyl testing. The CDC website states that fentanyl test strips are a low-cost method of helping prevent drug overdoses and reducing harm. The strips are small pieces of paper that can detect the presence of fentanyl in all different kinds of drugs (cocaine, methamphetamine, heroin, etc.) and drug forms (pills, powder, and injectables). They provide people who use drugs and communities, with important information about fentanyl in the illicit drug supply so they can take steps to reduce risk of overdose. In April 2021, the CDC and the Substance Abuse and Mental Health Services Administration announced federal funding could be used to purchase fentanyl test strips. This purchase approval applies to all federal grant programs, like CDC’s multiyear Overdose Data to Action cooperative agreement, if the purchase of the strips is consistent with the purpose of the program. The CDC states that allowing federal grant programs to purchase the strips helps create opportunities for people who use drugs to interact with community-based organizations who may also offer the behavioral health services a person needs.
- Addressing opioids among K-12 students. The California Department of Education (CDE), in conjunction with CDPH, provides LEAs with resources and information that they can readily share with parents and students to help keep them safe. The shareable Fentanyl Awareness and Prevention toolkit page offers information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
- Double referral. This bill was heard in the Senate Committee on Education on March 20, 2024, and passed with a 7-0 vote.
- Related legislation. SB 1442 (Ochoa-Bough), as part of the Senate’s “Working Together for a Safer California” to combat the fentanyl crisis, permits California Health and Human Services Agency to enter into partnerships for the manufacture or purchase of any federally approved point-of-care fentanyl tests, as specified. SB 1442 is set for hearing on April 22, 2024 in the Senate Appropriations Committee.
- Prior legislation. SB 472 (Hurtado of 2023) would have required each individual public school operated by an LEA to maintain at least two doses of naloxone or another opioid antagonist on its campus. SB 472 would have required those entities to report to CDE and the Department of Health Care Services (DHCS) specified information by July 31, 2024, and annually thereafter. SB 472 was held on the Senate Appropriations suspense file.
AB 461 (Ramos, Chapter 525, Statutes of 2023) requires the governing board of each California Community College and the Trustees of the California State University to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023), among other items, provides $3.5 million ongoing Proposition 98 General Fund to COEs to distribute opioid antagonists, with the intent that it complement efforts of DHCS’s Naloxone Distribution Project.
SB 10 (Cortese, Chapter 856, Statutes of 2023) requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; requires the CDE to post informational materials on its website on opioid overdose prevention; and encourages COEs to establish working groups on fentanyl education in schools.
- Support. Supporters of this bill state that fentanyl is one of the overarching drugs driving the rate of drug related overdoses in California and the United States. When laced, fentanyl is undetectable unless a fentanyl test strip is utilized. In the case of an opioid overdose, naloxone can help counteract its effects. Supporters cite CDC statistics, noting 15% of high school students reported using illicit or injection drugs, and 14% misused prescription opioids. Supporters argue these sobering statistics underscore the necessity of this bill’s preventative strategies to combat opioid misuse and potential overdoses in school settings. Educating students, families, and communities about these risks, along with making naloxone and fentanyl testing strips widely available, can significantly mitigate the potential for overdose and support healthier outcomes for at-risk youth.
SUPPORT AND OPPOSITION:
Support: Alameda County Office of Education
American Academy of Pediatrics, California
California Association of Alcohol and Drug Program Executives
California Youth Empowerment Network
Generation Up
Mental Health America of California
Steinberg Institute
Oppose: None received
-- END --
SENATE COMMITTEE ON EDUCATION
Senator Josh Newman, Chair
2023 - 2024 Regular
Bill No: SB 997 Hearing Date: March 20, 2024
Author: | |||
Version: | January 31, 2024 | ||
Urgency: | No | Fiscal: | Yes |
Consultant: | Kordell Hampton | ||
Subject: Pupil health: naloxone hydrochloride nasal spray and fentanyl test strips.
NOTE: This bill has been referred to the Committees on Education and Health. A "do pass" motion should include referral to the Committee on Health.
SUMMARY
This bill would require middle and high schools operated by a local education agency (LEA) to stock and distribute fentanyl test strips, in addition to authorizing LEAs, county offices of education (COE), and charter schools to develop and adopt a policy that allows pupils in middle schools and high schools to carry federally approved naloxone hydrochloride (naloxone).
BACKGROUND
Existing Law:
Education Code (EC)
- Requires the governing board of each community college district (CCD) and the Trustees of the California State University (CSU), and requests the Regents of the University of California (UC), to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center. (EC § 67384)
- Requires COEs, among other requirements, to be eligible for funds to purchase at least two units for each middle school, junior high school, high school, and adult school schoolsite within their jurisdiction, but are not required to participate. (EC § 49414.8)
- Requires an LEA that serve pupils in any of grades 7 to 12, to include in their school safety plan, a protocol in the event a pupil is suffering or is reasonably believed to be suffering from an opioid overdose. (EC § 32282(K))
- Permits a school nurse or trained personnel who has volunteered to provide emergency naloxone or another opioid antagonist, by nasal spray or by auto-injector, to persons suffering, or reasonably believed to be suffering, from an opioid overdose. (EC § 49414.3(a))
- Requires an LEA, COE, or charter school electing to utilize naloxone or another opioid antagonist for emergency aid to ensure that each employee who volunteers are provided defense and indemnification by the LEA, COE, or charter school for any and all civil liability. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteer’s personnel file. (EC § 49414.3(i))
- Provides a school no more than two weeks to restock their supply of naloxone or another opioid antagonist after use. (EC § 49414.3(h)
Civil Code (CIV)
- Permits a licensed health care provider who is authorized by law to prescribe an opioid antagonist to issue standing orders for the distribution of an opioid antagonist to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist a person at risk of an opioid-related overdose. (CIV § 1714.22 et. sq.)
ANALYSIS
This bill
- Authorizes an LEA to develop and adopt a policy that allows pupils in middle schools and high schools to carry federally approved naloxone to use for the emergency treatment of persons suffering, or reasonably believed to be suffering, from an opioid overdose.
- Require an LEA to do the following for middle and high schools with in their jurisdiction:
- Stock and distribute fentanyl test strips in a secured location along with written instructions on how to properly use the fentanyl test strips.
- Notify pupils of the presence and location of fentanyl test strips.
- Defines “LEA” as a school district, county office of education, or charter school.
STAFF COMMENTS
- Need for the bill. According to the author, “It is nearly impossible to tell if drugs have been laced with fentanyl unless you test your drugs with testing strips. Drug testing strips still hold a negative association with drug use, thereby stigmatizing this lifesaving tool. If we want to help our young people, we must take steps that preserve their livelihood. Test strips are inexpensive and typically give results within 5 minutes, which can be the difference between life or death. Naloxone is a life-saving medication that can reverse an opioid overdose. Naloxone is safe and easy to use and works almost immediately. It is now available over the counter, without a prescription at pharmacies, convenience stores, grocery stores. Similar to the testing strips, if we permit our young people to carry with live saving tools like Narcan and other opioid antagonists, we can respond to an opioid overdose faster.”
- Addressing Fentanyl Among California Youth. Pursuant to AB 1748 (Mayes, Chapter 557, Statutes of 2016), among other things, requires the Superintendent of Public Instruction is required to establish minimum training standards for school employees who volunteer to administer naloxone or another opioid antagonist. In addition to setting minimum training standards, the CDE must maintain on its website a clearinghouse for best practices in training nonmedical personnel to administer naloxone or another opioid antagonist to pupils.
The CDE, in conjunction with the California Department of Public Health (CDPH), provides LEAs with resources and information that they can readily share with parents and students to help keep them safe. The shareable Fentanyl Awareness and Prevention toolkit page offer information about the risks of fentanyl and how to prevent teen use and overdoses. In addition to the toolkit, the CDPH’s Substance and Addiction Prevention branch also provides resources for parents, guardians, caretakers, educators, schools, and youth-serving providers.
While schools are authorized but not required to stock naloxone, some LEAs and COEs have also adjusted to address this growing crisis. For example, the Lake County Office of Education and Washington Unified School District in West Sacramento recently implemented a local school naloxone policy consistent with state statutes (which requires school employees who elect to administer naloxone, to be trained in the administration, and to keep the naloxone stocked and stored appropriately). San Diego Unified School District created its naloxone toolkit to aid other LEAs and inform parents and guardians.
Further, the legislature has adopted a series of legislation such as SB 10 (Cortese, Chapter 856, Statutes of 2023), which requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023) that, among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists, with the intent that it complement efforts of the Naloxone Distribution Project; and AB 889 (Joe Patterson, Chapter 123, Statutes of 2023) which required LEA, COE, and charter school to annually inform parents or guardians of the dangers associated with using synthetic drugs and post this information on their respective internet websites.
- Statewide Standing Order for Naloxone. Naloxone can help reduce opioid overdose deaths in California, but many organizations find it challenging to obtain the required standing order to get naloxone from healthcare providers. CDPH issued the standing order in 2017 to address this need and support equitable naloxone access. The standing order:
- Allows community organizations and other non-prescribing entities (organizations that do not employ or contract with a medical provider that has a license to prescribe and can issue a standing order and provide oversight for the distribution and administration of naloxone) in California that are not currently working with a physician to distribute naloxone to a person at risk of an opioid-related overdose or to a family member, friend, or another person in a position to assist; and
- Allows for the administration of naloxone by a family member, friend, or other person to a person experiencing or reasonably suspected of experiencing an opioid overdose.
Among the organizations and entities that can distribute naloxone under the order are colleges and universities. An individual at risk of experiencing an overdose or someone who can assist an individual at risk is allowed to do so. Under the statewide standing order, staff of community organizations and other entities distributing naloxone must be trained. They are also required to provide training to individuals who receive naloxone from them. Colleges, schools, and other organizations may apply to use the statewide standing order if they meet certain conditions.
- The U.S. Food and Drug Administration: Approval of Over-The-Counter Naloxone. On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.
The FDA first approved naloxone nasal spray in 2015 as a prescription drug. In accordance with a process to change the status of a drug from prescription to nonprescription, the manufacturer provided data demonstrating that the drug is safe and effective for use as directed in its proposed labeling. The manufacturer also showed that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional. The application to approve naloxone nasal spray for OTC use was granted priority review status and was the subject of an advisory committee meeting in February 2023, where committee members voted unanimously to recommend it be approved for marketing without a prescription.
On July 28, 2023, the FDA approved RiVive, a (3mg) naloxone nasal spray for OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription.
This bill allows LEAs to adopt policies that would permit students to carry federally approved naloxone nasal spray for OTC, nonprescription use solely, potentially limiting other OTC opioid reversal medications that may be adopted by the FDA in the future. The committee may wish to consider not limiting opioid reversal medication solely to OTC nasal sprays and allowing for any federally approved opioid antagonist. This bill has been referred to the Committees on Education and Health where this can be considered further.
- Naloxone: Training Requirements. Civil Code 1714.22 requires a person who is prescribed or possesses an opioid antagonist, pursuant to the standing order, to receive training provided by an opioid overdose prevention and treatment training program (CIV 1714.22 (d)). This includes learning the causes of an opiate overdose, mouth-to-mouth resuscitation, how to contact appropriate emergency medical services, and how to administer an opioid antagonist (CIV 1714.22 (a)(2)). While CDPH makes opioid reversal medication training available online through its website, current statute does not require an individual who purchases OTC opioid reversal medication to receive training.
Are There Other Training Programs Available?
The American Red Cross provides a First Aid for Opioid Overdoses Online course that teaches persons to identify the signs and symptoms of a suspected opioid overdose and then the appropriate care to provide based on the responsiveness of the person. This course includes information on how to use several different naloxone products -- a nasal atomizer, Narcan and EVZIO -- to reverse the effects of an opioid overdose. According to the American Red Cross website, this “interactive course includes audio and video and takes approximately 45 minutes to complete. [A person] must pass a final quiz to complete the course.” The American Red Cross provides this online training for $20.
This bill would allow LEAs, COEs, and charter schools to establish a policy that would allow students to carry naloxone on campus. The committee may wish to consider aligning the procurement of naloxone with the standing order to ensure students that may wish to carry naloxone on campus have received training to ensure proper administration to potentially other students on school campus.
Committee staff recommends that adopted polices to allow students to carry naloxone on school campus, to include, at a minimum, training. This would ensure that a students who elects to carry naloxone on campus are knowledge in the administration, in a similar manner to a school employee who must go through training before being able to administer naloxone to a student on campus.
- Fentanyl test strips. According to CDPH’s website, fentanyl test strips are a harm reduction strategy. Anyone can purchase and use fentanyl test strips, which cost approximately $1 each and can be purchased from several vendors and businesses. Free or low-cost fentanyl test strips are available to individuals at California’s syringe services programs through the California Harm Reduction Supplies Clearinghouse. In order to use the strips, testers dissolve a small amount of substance in water, and then dip the test strip into the liquid for 15 seconds. Because the test strips are highly sensitive, a minimal amount of drug residue is sufficient to obtain a result. The test strip is then set on a flat surface until results appear, typically within 5 minutes.
Last year, the Legislature passed SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023), which among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists at middle school, junior high school, high school, and adult school, with the intent that it complement efforts of the Naloxone Distribution Project. To align with the schools that may receive naloxone pursuant to SB 114 and the state’s efforts, the committee may wish to consider including junior high and adult schools.
- Committee Amendments. The committee recommends, and the author has agreed to accept, the following amendments:
- Adds junior high and adult schools to the list of school sites within a LEA’s jurisdiction to include the storage and distribution of fentanyl test strips.
- Require polices adopted by LEAs, COEs, and charter schools to include, at a minimum, instruction for students who elect to carry naloxone on school campus.
- Allows for any federally approved naloxone to be carried on school campus by student
- Adds coauthors
- Related Legislation.
AB 461 (Ramos, Chapter 525, Statutes of 2023) requires the governing board of each CCD and the Trustees of the CSU to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
SB 114 (Committee on Budget and Fiscal Review, Chapter 48, Statutes of 2023), among other items, provides $3.5 million ongoing Proposition 98 General Fund to COE to distribute opioid antagonists, with the intent that it complement efforts of the Naloxone Distribution Project.
SB 10 (Cortese, Chapter 856, Statutes of 2023) requires school safety plans of schools, including charter schools, serving students in grades 7 to 12 to include a protocol for responding to a student's opioid overdose; requires the California Department of Education (CDE) to post informational materials on its website on opioid overdose prevention; and encourages COEs to establish working groups on fentanyl education in schools.
SUPPORT
Alameda County Office of Education
American Academy of Pediatrics, California
California Association of Alcohol and Drug Program Executives
California Youth Empowerment Network
Generation Up
Steinberg Institute
OPPOSITION
None Received
-- END --
Discussed in Hearing
Assembly Floor
Assembly Standing Committee on Education
Senate Standing Committee on Health
Senate Standing Committee on Health
Bill Author
Bill Co-Author(s):